Serum Institute Of India Enters Into New Landmark Partnership

Reports are coming from serum Institute of India that Serum Institute of India enters into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of 200 million doses of covid-19 vaccine for India and other low income countries. 

According to the report coming from Serum Institute of India that the funding will support at risk manufacturing by Serum Institute of India for candidate vaccine from AstraZeneca and Novavax, which will be available for procurement if they are successful in obtaining full licensure and World Health Organisation prequalification. 

📝 Summary:

Generating summary...